Recombination efficiency of SMMHC-CreERT2, SMArTTa-tetOCre, smMHCCre/eGFP, and c-KitCreERT2 lines with ROSA26mT/mG. (A) Representative immunofluorescence maximal projections of a fixed SMMHC-CreERT2-ROSA26mT/mG IALV stained for GFP and SMA to determine recombination efficiency. (B) Representative immunofluorescence maximal projections of a fixed SMArTTa-tetOCre-ROSA26mT/mG IALV stained with antibodies for GFP and SMA to determine recombination efficiency. (C) Representative immunofluorescence maximal projections of a smMHCCre/eGFP IALV fixed and stained for GFP and SMA to determine recombination efficiency. (A–C) Comparisons of cell masks for SMA and GFP to highlight cells that were SMA-positive/GFP-negative and the merged maximal projection used to assess recombination efficiency. (D) Representative immunofluorescence maximal projections of a live and pressurized (2 cm H2O) c-KitCreERT2-ROSA26mT/mG IALV imaged for GFP (recombined cells) and td-tomato (not recombined). Images were taken at 20× objective magnification. (E) Representative immunofluorescent images of the intestine muscle layer of a c-KitCreERT2-ROSA26mT/mG induced with our tamoxifen injection protocol and acquired using a fluorescence macroscope revealed recombination of the c-Kit+ interstitial cells of Cajal. RFP, red fluorescent protein (tdTomato); GFP, green fluorescent protein (EGFP).